Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05687643
Other study ID # VS21/143856
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date July 1, 2022
Est. completion date April 3, 2024

Study information

Verified date July 2023
Source The Leeds Teaching Hospitals NHS Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Stain Analysis Mapping of the Plantar surface (STAMP) is a method designed by the University of Leeds to measure 'in-shoe' strain patterns on the plantar surface of the foot. Shear Load Inductive Plantar Sensing (SLIPS) is an insole designed by the University of Leeds to measure plantar shear stress and plantar pressure. This study aims to compare plantar strain using STAMP and plantar shear stress and plantar pressure using SLIPS in two groups of patients with diabetes; high risk patients with a recently healed plantar ulcer and low risk patients (according to the NICE definition).


Description:

Stain Analysis Mapping of the Plantar surface (STAMP) is a method designed by the University of Leeds to measure 'in-shoe' strain patterns on the plantar surface of the foot. The insole comprises a pseudorandom pattern applied to a plastically deformable insole using a temporary tattoo layer. STAMP utilises digital image correlation to track the deformation of the pattern following a period of walking. Shear Load Inductive Plantar Sensing (SLIPS) is an insole designed by the University of Leeds to measure plantar shear stress and plantar pressure. SLIPS is an insole which integrates 64 tri-axis soft force sensors which simultaneously measures shear stress and pressure. The SLIPS insole has been designed to measure the plantar load of the right foot and due to its size can only be accommodated by a size 8-11 shoe. The commercial device Pedar (Novel gmbh) will be used as a reference for plantar pressure measurement in both groups. This study aims to compare plantar strain using STAMP and plantar shear stress and plantar pressure using SLIPS in two groups of patients with diabetes; high risk patients with a recently healed plantar ulcer and low risk patients (according to the NICE definition). It is hypothesised that patients with a recently healed plantar ulcer with exhibit elevated plantar strain, plantar shear stress and plantar pressure than the low risk group.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 60
Est. completion date April 3, 2024
Est. primary completion date April 3, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility DFU group: Patients will undergo STAMP and Pedar assessment if they fulfil the following criteria. Inclusion Criteria: 1. Age >18 2. A diagnosis of diabetes mellitus 3. A diagnosis of diabetic peripheral neuropathy 4. Recently healed plantar ulcer (within the last 3 months) 5. Able to provide informed consent 6. Previous open or endovascular revascularisation SLIPS inclusion criteria: Patients will also undergo assessment with the SLIPS insole if they fulfil the following inclusion criteria: 1. Recently healed plantar DFU located on the right foot 2. The right foot can be accommodated in a size 8-11 shoe 3. Weight <100kg Low risk group: Patients will undergo STAMP and Pedar assessment if they fulfil the following criteria: 1. Age >18 2. A diagnosis of diabetes mellitus 3. Low risk for DFU according to the NICE NG 19 guidelines (no risk factors for ulceration except callus alone) 4. Able to provide informed consent Exclusion Criteria: 1. Unable to mobilise independently 150m without the use of walking aids and thus unable to complete the walking assessments 2. Previous ipsilateral minor amputation 3. Previous ipsilateral surgical offloading procedure 4. Previous contralateral major amputation 5. Ipsilateral toe pressure <40mmHg SLIPS assessment inclusion: 1. The right foot can be accommodated in a size 8-11 shoe 2. Weight <100kg Exclusion criteria: 1. Unable to mobilise independently 150m without the use of walking aids and thus unable to complete the walking assessments 2. Previous ipsilateral minor amputation 3. Presence of a foot deformity 4. Previous contralateral major amputation 5. Ipsilateral toe pressure <40mmHg

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United Kingdom Leeds Teaching Hospitals NHS Trust Leeds West Yorkshire

Sponsors (1)

Lead Sponsor Collaborator
The Leeds Teaching Hospitals NHS Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Peak plantar strain The difference in peak plantar strain (%) (as measured with STAMP) between the DFU and low risk group At clinical visit on study entry
Secondary Regional peak plantar strain The difference in regional peak plantar strain (%) between the DFU and low risk group at the 10 pre-specified regions: heel, midfoot, 1st metatarsal head (MTH), 2nd MTH, 3rd MTH, 4th MTH, 5th MTH, hallux, 2nd toe, toes 3-5 At clinical visit on study entry
Secondary Regional peak plantar shear The difference in regional peak plantar shear (kPa) between the DFU and low risk group at the 10 pre-specified regions: heel, midfoot, 1st metatarsal head (MTH), 2nd MTH, 3rd MTH, 4th MTH, 5th MTH, hallux, 2nd toe, toes 3-5 At clinical visit on study entry
Secondary Peak Plantar pressure Global peak plantar pressure (kPa) between DFU and low risk groups. At clinical visit on study entry
Secondary Regional Peak Plantar pressure Regional peak plantar pressure (kPa) between DFU and low risk groups At clinical visit on study entry
See also
  Status Clinical Trial Phase
Recruiting NCT04497805 - Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers Phase 2
Withdrawn NCT03675269 - Adjunctive Hyperbaric Oxygen Therapy (HBOT) for Lower Extermity Diabetic Ulcer: N/A
Completed NCT04624516 - Effect of Self-foot Exercise on the Incidence of Plantar Foot Diabetic Ulcer Recurrence N/A
Not yet recruiting NCT06439667 - VIRTUALLY SUPERVISED TELE-EXERCISE PLATFORM FOR ACCELERATING PLANTAR WOUND HEALING
Recruiting NCT05608187 - Evaluating Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot Ulcers Phase 2
Not yet recruiting NCT06278935 - Lifestyle Tailored Offloading for Diabetic Foot Ulcers N/A
Not yet recruiting NCT06437028 - Evaluating the Efficacy of Perinatal Membrane Allografts for the Treatment of Diabetic Foot Ulcers. N/A
Withdrawn NCT05024656 - AmnioExcel® Plus vs SOC in the Management of Diabetic Foot Ulcers N/A
Terminated NCT02202668 - Transcutaneous Raman Spectroscope (TRS) Analyses of Diabetic Foot Ulcers N/A
Terminated NCT01966380 - Proof of Concept (Design Validation) in Patient With Hard to Heal Wounds Such as Pressure Ulcer, Diabetic Foot Ulcer and Leg Ulcer, Leia Phase 2
Completed NCT01951768 - Efficacy and Safety of Garamycin® Sponge in Diabetic Patients With a Moderate or Severe Foot Ulcer Infection Phase 4
Completed NCT01657474 - Comparative Study of Two Application Regimens of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers N/A
Active, not recruiting NCT00389636 - TheraGauzeā„¢ Alone and Regranex®Gel 0.01% Plus TheraGauzeā„¢ in the Treatment of Wagner Stage I Diabetic Foot Ulcers N/A
Completed NCT01181440 - Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers Phase 3
Enrolling by invitation NCT05888259 - Plantar Pressure Distribution in Diabetic Foot Ulcer N/A
Completed NCT04054804 - Digital Foot Check by Using the D-Foot, a New Software
Not yet recruiting NCT05877378 - Efficacy of PICO Single-use System in Chronic Ulcers N/A
Recruiting NCT06037369 - The Short Message-based Customized Standardized N/A
Completed NCT03312595 - Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) N/A
Recruiting NCT04564443 - A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot N/A